These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 16598437)
1. Antiangiogenic effect of 2-benzoyl-phenoxy acetamide in EAT cell is mediated by HIF-1alpha and down regulation of VEGF of in-vivo. Prabhakar BT; Khanum SA; Shashikanth S; Salimath BP Invest New Drugs; 2006 Nov; 24(6):471-8. PubMed ID: 16598437 [TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic and antiproliferative effects of substituted-1,3,4-oxadiazole derivatives is mediated by down regulation of VEGF and inhibition of translocation of HIF-1alpha in Ehrlich ascites tumor cells. Kumar A; D'Souza SS; Nagaraj SR; Gaonkar SL; Salimath BP; Rai KM Cancer Chemother Pharmacol; 2009 Nov; 64(6):1221-33. PubMed ID: 19370348 [TBL] [Abstract][Full Text] [Related]
3. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells. Chen MC; Lee CF; Huang WH; Chou TC Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116 [TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic effects of a novel synthetic curcumin analogue in pancreatic cancer. Nagaraju GP; Zhu S; Ko JE; Ashritha N; Kandimalla R; Snyder JP; Shoji M; El-Rayes BF Cancer Lett; 2015 Feb; 357(2):557-65. PubMed ID: 25497868 [TBL] [Abstract][Full Text] [Related]
5. Molecular and functional evaluation of a novel HIF inhibitor, benzopyranyl 1,2,3-triazole compound. Park K; Lee HE; Lee SH; Lee D; Lee T; Lee YM Oncotarget; 2017 Jan; 8(5):7801-7813. PubMed ID: 27999195 [TBL] [Abstract][Full Text] [Related]
6. The effect of indatraline on angiogenesis suppression through HIF-1α-mediated VEGF inhibition. Yen CN; Cho YS; Kwon HJ Biochem Biophys Res Commun; 2017 Apr; 485(2):349-354. PubMed ID: 28216154 [TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1α and STAT-3. Nagaraju GP; Park W; Wen J; Mahaseth H; Landry J; Farris AB; Willingham F; Sullivan PS; Proia DA; El-Hariry I; Taliaferro-Smith L; Diaz R; El-Rayes BF Angiogenesis; 2013 Oct; 16(4):903-17. PubMed ID: 23838996 [TBL] [Abstract][Full Text] [Related]
8. A tumoural angiogenic gateway blocker, Benzophenone-1B represses the HIF-1α nuclear translocation and its target gene activation against neoplastic progression. Thirusangu P; Vigneshwaran V; Ranganatha VL; Vijay Avin BR; Khanum SA; Mahmood R; Jayashree K; Prabhakar BT Biochem Pharmacol; 2017 Feb; 125():26-40. PubMed ID: 27838496 [TBL] [Abstract][Full Text] [Related]
9. Identification of novel antiangiogenic anticancer activities of deguelin targeting hypoxia-inducible factor-1 alpha. Oh SH; Woo JK; Jin Q; Kang HJ; Jeong JW; Kim KW; Hong WK; Lee HY Int J Cancer; 2008 Jan; 122(1):5-14. PubMed ID: 17764071 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of HIF-1alpha activity by BP-1 ameliorates adjuvant induced arthritis in rats. Shankar J; Thippegowda PB; Kanum SA Biochem Biophys Res Commun; 2009 Sep; 387(2):223-8. PubMed ID: 19664474 [TBL] [Abstract][Full Text] [Related]
12. Butyrate-induced proapoptotic and antiangiogenic pathways in EAT cells require activation of CAD and downregulation of VEGF. Belakavadi M; Prabhakar BT; Salimath BP Biochem Biophys Res Commun; 2005 Oct; 335(4):993-1001. PubMed ID: 16105646 [TBL] [Abstract][Full Text] [Related]
13. Apigenin inhibits tumor angiogenesis through decreasing HIF-1alpha and VEGF expression. Fang J; Zhou Q; Liu LZ; Xia C; Hu X; Shi X; Jiang BH Carcinogenesis; 2007 Apr; 28(4):858-64. PubMed ID: 17071632 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, angiopreventive activity, and in vivo tumor inhibition of novel benzophenone-benzimidazole analogs. Ranganatha VL; Vijay Avin BR; Thirusangu P; Prashanth T; Prabhakar BT; Khanum SA Life Sci; 2013 Nov; 93(23):904-11. PubMed ID: 24135459 [TBL] [Abstract][Full Text] [Related]
15. Combinatorial antitumor effect of naringenin and curcumin elicit angioinhibitory activities in vivo. Anand K; Sarkar A; Kumar A; Ambasta RK; Kumar P Nutr Cancer; 2012; 64(5):714-24. PubMed ID: 22642894 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of Ehrlich ascites cancer, hypoxia-inducible factor-1 alpha, and the kinase insert domain-containing receptor/ Madhu LN; Telkar S; Kamath D; D Souza ME; Rao S; Nayak PS; Sarojini BK J Cancer Res Ther; 2020 Dec; 16(Supplement):S74-S81. PubMed ID: 33380656 [TBL] [Abstract][Full Text] [Related]
17. Pseudolaric acid B inhibits angiogenesis and reduces hypoxia-inducible factor 1alpha by promoting proteasome-mediated degradation. Li MH; Miao ZH; Tan WF; Yue JM; Zhang C; Lin LP; Zhang XW; Ding J Clin Cancer Res; 2004 Dec; 10(24):8266-74. PubMed ID: 15623602 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of hypoxia inducible factor-1alpha by dihydroxyphenylethanol, a product from olive oil, blocks microsomal prostaglandin-E synthase-1/vascular endothelial growth factor expression and reduces tumor angiogenesis. Terzuoli E; Donnini S; Giachetti A; Iñiguez MA; Fresno M; Melillo G; Ziche M Clin Cancer Res; 2010 Aug; 16(16):4207-16. PubMed ID: 20682710 [TBL] [Abstract][Full Text] [Related]
19. Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis. Wang J; Li G; Wang Y; Tang S; Sun X; Feng X; Li Y; Bao G; Li P; Mao X; Wang M; Liu P Oncotarget; 2015 Dec; 6(42):44579-92. PubMed ID: 26625311 [TBL] [Abstract][Full Text] [Related]
20. Antiangiogenic activity of genistein in pancreatic carcinoma cells is mediated by the inhibition of hypoxia-inducible factor-1 and the down-regulation of VEGF gene expression. Büchler P; Reber HA; Büchler MW; Friess H; Lavey RS; Hines OJ Cancer; 2004 Jan; 100(1):201-10. PubMed ID: 14692041 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]